Refining the Role of Contrast-enhanced Mammography in Breast Cancer Screening: Insights from the RACER Trial
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Miao S, Ni Q, Fang J Breast J. 2025; 2024:4434466.
PMID: 39742384 PMC: 11561182. DOI: 10.1155/2024/4434466.
References
1.
Bretthauer M, Kalager M
. Principles, effectiveness and caveats in screening for cancer. Br J Surg. 2012; 100(1):55-65.
DOI: 10.1002/bjs.8995.
View
2.
Oluwasanu M, Olopade O
. Global disparities in breast cancer outcomes: new perspectives, widening inequities, unanswered questions. Lancet Glob Health. 2020; 8(8):e978-e979.
PMC: 7375795.
DOI: 10.1016/S2214-109X(20)30307-7.
View
3.
Pesapane F, Rotili A, Raimondi S, Aurilio G, Lazzeroni M, Nicosia L
. Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity. Eur J Radiol. 2024; 172:111321.
DOI: 10.1016/j.ejrad.2024.111321.
View
4.
Neeter L, Nelemans P, Raat H, Frotscher C, Duvivier K, Essers B
. Contrast-enhanced mammography versus conventional imaging in women recalled from breast cancer screening (RACER trial): a multicentre, open-label, randomised controlled clinical trial. Lancet Reg Health Eur. 2024; 44:100987.
PMC: 11268340.
DOI: 10.1016/j.lanepe.2024.100987.
View